This transaction
Business AcquisitionContract editorial services, tie-up advertising and PR business built around the health media brand “Karada ni Ii Koto”
The impact on results for the fiscal year ending March 2027 is expected to be minor.
| Item | Details |
|---|---|
| Transaction name | Business Acquisition |
| Counterparty name | 株式会社セントラルメディエンス |
| Business Description of the Subject Company | Contract editorial services, tie-up advertising and PR business built around the health media brand “Karada ni Ii Koto” |
| Net Sales of the Subject Company | ¥188 million (fiscal year ended April 2026) |
| Net Assets of the Subject Company | ¥15 million (fiscal year-end not stated) |
| Acquisition price | ¥51 million (planned) |
| Type of Consideration | Cash |
| Goodwill amount | The amount to be recognized and the amortization period are currently under review |
| Impact on Business Performance | The impact on results for the fiscal year ending March 2027 is expected to be minor. |
| Date of board resolution | 11 September 2026 |
| Contract Date | 14 September 2026 |
| Execution Date / Effective Date | 14 September 2026 (scheduled) |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The acquisition is intended to strengthen the media business’s editorial capabilities by incorporating the expertise and resources developed by “Karada ni Ii Koto.” The Company expects the acquisition of publishing rights to expand its information distribution channels beyond online media to include publications and other formats, creating synergies with its medical platform business and expanding the foundation of its media business.